Login to Your Account

Blockbuster Deal In England: CAT Acquiring OGS For $177M

By Nuala Moran

Friday, January 24, 2003
Cambridge Antibody Technology Group plc plans to acquire Oxford GlycoSciences plc in an all-share deal valuing OGS at £109.6 million (US$177 million). The deal would create a company with a £260 million cash pile and a market capitalization of around £289 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription